Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Introduction: High spontaneous activity of the renin–angiotensin system (RAS) results in more pronounced cognitive impairment and more prolonged QTc interval during hypoglycaemia in type 1 diabetes. We tested whether angiotensin II receptor blockade improves cerebral and cardiovascular function during hypoglycaemia. Methods: Nine patients with type 1 diabetes and high spontaneous RAS activity were included in a double-blind, randomised, cross-over study on the effect of angiotensin II receptor antagonist (candesartan 32 mg) or placebo for one week on cognitive function, cardiovascular parameters, hormonal counter-regulatory response, substrate mobilisation, and symptoms during hypoglycaemia induced by two hyperinsulinaemic, hypoglycaemic clamps. Results: Compared to placebo, candesartan did neither change performance of the cognitive tests nor the EEG at a plasma glucose concentration of 2.6±0.2 mmol/l. During candesartan treatment, the QT interval in the ECG was not affected. No effect of candesartan was observed in the hormonal counter-regulatory responses, in substrate concentrations, or in symptom scores. A 36% reduced glucose infusion rate during hypoglycaemia with candesartan was observed. Conclusion: In conclusion candesartan has no effect on cerebral function during mild experimental hypoglycaemia in subjects with type 1 diabetes and high RAS activity. Candesartan may reduce glucose utilisation or increase endogenous glucose production during hypoglycaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with our results, previous studies showed no impact of angiotensin II receptor blockade on hypoglycemia-induced QTc prolongation (26).”
From Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial (2025) · cites this paper as [26]
Citations
Cites
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Selnes, O. A. (1991) · Neurology · doi:10.1212/wnl.41.11.1856-a · Cited by 2,252
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“55 Stroop word, items completed 104 (17) 86 (16) <0.”
Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433
Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 401
Pedersen‐Bjergaard, U., Pramming, S., Heller, S. R., Wallace, T. M., Rasmussen, Å. K., Jørgensen, H. V., Matthews, D. R., Hougaard, P., & Thorsteinsson, B. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.482 · Cited by 371 · cited 2×
“05 NA Trail-making B test, s 33 (9) 44 (25) 0.”
Self-citationGill, G. V., Woodward, A., Casson, I. F., & Weston, P. J. (2009) · Diabetologia · doi:10.1007/s00125-008-1177-7 · Cited by 294 · cited 1×
“Heart rate, beats/min 72 (13) 73 (14) 0.”
Saavedra, J. M., Sánchez-Lemus, E., & Benicky, J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.001 · Cited by 260
Recall of severe hypoglycaemia and self‐estimated state of awareness in type 1 diabetes
Pedersen‐Bjergaard, U., Pramming, S., & Thorsteinsson, B. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.377 · Cited by 240 · cited 1×
“7) AT2R AG genotype (AA/AG/GG) (n) 8/1/0 Serum ACE activity (U/l) 49 (21) Angiotensinogen (nmol/l)b 1133 (183)”
Self-citationPedersen‐Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P., & Thorsteinsson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04405-6 · Cited by 141 · cited 2×
“Number of participants (females) (n) 9 (1) Age (years) 56 (9.”
MethodSelf-citationNishimura, Y., Ito, T., Hoe, K., & Saavedra, J. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02377-5 · Cited by 136
More on Neuropathy from Pyridoxine Abuse
Berger, A., & Schaumburg, H. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410113111513 · Cited by 127
Pedersen‐Bjergaard, U., Agerholm-Larsen, B., Pramming, S., Hougaard, P., & Thorsteinsson, B. (2003) · Diabetologia · doi:10.1007/s00125-002-0969-4 · Cited by 101 · cited 1×
“The patients were placed in a comfortable resting chair and were equipped with (1) two intravenous antecubital lines for infusion of insulin and glucose and for blood sampling, (2) electroencephalography (EEG) cap, two ear lobe references and two precordial ECG leads connected to a digital EEG recorder (Cadwell, Kenne…”
MethodSelf-citationEthnicity influences morphine pharmacokinetics and pharmacodynamics
Cepeda, M. S., Farrar, J. T., Roa, J. H., Boston, R., Meng, Q. C., Ruiz, F., Carr, D. B., & Strom, B. L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)51508-8 · Cited by 96
Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT1 Receptor Antagonists in the Brain
Saavedra, J. M., Benický, J., & Zhou, J. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9009-0 · Cited by 83
Hoist, J. J. (1983) · Diabetologia · doi:10.1007/bf00251825 · Cited by 77
Comprehensive Trail Making Test
Gray, R. (2006) · Journal of Psychoeducational Assessment · doi:10.1177/0734282905282415 · Cited by 74
Gruden, G., Giunti, S., Barutta, F., Chaturvedi, N., Witte, D. R., Tricarico, M., Fuller, J. H., Cavallo Perin, P., & Bruno, G. (2012) · Diabetes Care · doi:10.2337/dc11-1739 · Cited by 61
Serum ACE Predicts Severe Hypoglycemia in Children and Adolescents With Type 1 Diabetes
Nordfeldt, S., & Samuelsson, U. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.274 · Cited by 45 · cited 6×
“1044 Journal of the Renin-Angiotensin-Aldosterone System 16(4)”
MethodInfluentialLosartan attenuates symptomatic and hormonal responses to hypoglycemia in humans
Deininger, E., Oltmanns, K. M., Wellhoener, P., Fruehwald‐Schultes, B., Kern, W., Heuer, B., Dominiak, P., Born, J., Fehm, H. L., & Peters, A. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)26448-0 · Cited by 39
Kristensen, P. L., Pedersen-Bjergaard, U., Kjær, T. W., Olsen, N. V., Dela, F., Holst, J. J., Faber, J., Tarnow, L., & Thorsteinsson, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059672 · Cited by 37
Self-citationZammitt, N. N., Geddes, J., Warren, R. E., Marioni, R., Ashby, J. P., & Frier, B. M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02263.x · Cited by 35 · cited 1×
“The patients were placed in a comfortable resting chair and were equipped with (1) two intravenous antecubital lines for infusion of insulin and glucose and for blood sampling, (2) electroencephalography (EEG) cap, two ear lobe references and two precordial ECG leads connected to a digital EEG recorder (Cadwell, Kenne…”
MethodComprehensive Trail Making Test
Dumont, R., & Willis, J. O. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0479 · Cited by 34
Pedersen‐Bjergaard, U., Dhamrait, S. S., Sethi, A. A., Frandsen, E., Nordestgaard, B. G., Montgomery, H., Pramming, S., Hougaard, P., & Thorsteinsson, B. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.12.002 · Cited by 28
Self-citationEffects of a controlled hypoglycaemia test on QTc in adolescents with Type 1 diabetes
Rothenbühler, A., Bibal, C., Fur, S. L., & Bougneres, P. F. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02599.x · Cited by 27
Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans
Oltmanns, K. M., Deininger, E., Wellhoener, P., Schultes, B., Kern, W., Marx, E., Dominiak, P., Born, J., Fehm, H. L., & Peters, A. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01771.x · Cited by 16 · cited 1×
“Systolic blood pressure, mmHg 120 (28) 115 (22) 0.”
McCrimmon, R. J., Deary, I. J., Gold, A. E., Hepburn, D. A., MacLeod, K. M., Ewing, F. M. E., & Frier, B. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00955_3.x · Cited by 16
Takezako, T., Zhang, B., Serikawa, T., Fan, P., Nomoto, J., & Saku, K. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.603 · Cited by 16 · cited 2×
“Diastolic blood pressure, mmHg 73 (16) 67 (15) 0.”
Due-Andersen, R., Høi-Hansen, T., Larroudé, C. E., Olsen, N. V., Kanters, J. K., Boomsma, F., Pedersen‐Bjergaard, U., & Thorsteinsson, B. (2008) · EP Europace · doi:10.1093/europace/eun137 · Cited by 16 · cited 1×
“Heart rate, beats/min 72 (13) 73 (14) 0.”
Self-citationPedersen‐Bjergaard, U., Thomsen, C. E., Høgenhaven, H., Smed, A., Kjær, T. W., Holst, J. J., Dela, F., Hilsted, L., Frandsen, E., Pramming, S., et al. (2008) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2008.001 · Cited by 14
Self-citationCardiac arrhythmias in hypoglycaemia.
Heller, S. R. (2002) · PubMed · Cited by 13
High serum ACE activity predicts severe hypoglycaemia over time in patients with type 1 diabetes
Færch, L., Pedersen‐Bjergaard, U., & Thorsteinsson, B. (2011) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.604132 · Cited by 12 · cited 1×
“Stroop word/colour, items completed 50 (7) 43 (15) 0.”
Self-citationJohannesen, J., Svensson, J., Bergholdt, R., Eising, S., Gramstrup, H. M., Frandsen, E., Dick-Nielsen, J., Hansen, L., Pociot, F., Mortensen, H. B., et al. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00660.x · Cited by 12
Høi-Hansen, T., Pedersen‐Bjergaard, U., Due-Andersen, R., Kristensen, P. L., Thomsen, C. E., Kjær, T. W., Høgenhaven, H., Smed, A., Holst, J. J., Dela, F., et al. (2009) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320309343007 · Cited by 11 · cited 2×
“The pre-study power calculation with a minimal relevant difference (MIREDIF) = 50 ms for mean reaction time prolongation (CalCAP, SRT2) and SD = 80 ms (10) and type 1 and type 2 error risks of 5% and 20%, respectively, showed that 20 patients should be included.”
MethodSelf-citationRingholm, L., Pedersen‐Bjergaard, U., Thorsteinsson, B., Boomsma, F., Damm, P., & Mathiesen, E. R. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.01.006 · Cited by 10
Self-citationPedersen-Bjergaard, L. (2008) · Cited by 1
Research works printed but not linked: 3
- Heller SR, 2002, Diabetes Nutr Metab, 15, 461
- Strauss E, 2006, A compendium of neuropsychological tests, 477
- Holst JJ, 1983, Diabetologia, 24, 359
Cited by
Fitzpatrick, C., Chatterjee, S., Seidu, S., Bodicoat, D. H., Ng, G. A., Davies, M. J., & Khunti, K. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13348 · Cited by 57
Hypoglycaemia and cardiac arrhythmias in diabetes
Andersen, A., Jørgensen, P. G., Knop, F. K., & Vilsbøll, T. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820911803 · Cited by 54
Hypoglycemia-Induced Changes in the Electroencephalogram: An Overview
Blaabjerg, L., & Juhl, C. B. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816659744 · Cited by 34
Andreasen, C. R., Andersen, A., Hagelqvist, P. G., Maytham, K. B., Lauritsen, J. V., Engberg, S., Faber, J. O., Pedersen‐Bjergaard, U., Knop, F. K., & Vilsbøll, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15005 · Cited by 15
“1%]), their body mass index was 26 (23-27) kg/m(2), and they had a diabetes duration of 23 (7-38) years.”
BackgroundSelf-citationHagelqvist, P. G., Andersen, A., Maytham, K. B., Andreasen, C. R., Engberg, S., Lindhardt, T. B., Faber, J. O., Holst, J. J., Forman, J. L., Pedersen‐Bjergaard, U., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14964 · Cited by 6
Self-citation
Metadata
- Authors
- Færch, L. H., Thorsteinsson, B., Tarnow, L., Holst, J. J., Kjær, T., Kanters, J., Larroude, C., Dela, F., & Pedersen-Bjergaard, U.
- Affiliations
- Nordsjællands Hospital (DK)
- University of Copenhagen (DK)
- Aarhus University (DK)
- Copenhagen University Hospital (DK)
- Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital – Frederikssund, Denmark
- Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital – Hillerød, Denmark
- Corresponding author
- Færch, Louise H
- Venue
- Journal of the Renin-Angiotensin-Aldosterone System
- Publisher
- SAGE Publications
- Published
- 2014-07-27
- Volume
- 16
- Issue
- 4
- Pages
- 1036-1045
- ISSN
- 1470-3203 (ISSN-L)
- 1752-8976
- OpenAlex
- W2131234584
- Cited by
- 8
- References
- 35
- Citations by year
- 2025: 2 · 2023: 3 · 2020: 1 · 2018: 1 · 2016: 1
- FWCI
- 0.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of the Renin-Angiotensin-Aldosterone System (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, hypoglycemia, angiotensin II receptor blockade, candesartan, renin-angiotensin system, cognitive function, QTc interval, counterregulatory response, hypoglycaemic symptoms, glucose infusion rate, endogenous glucose production
- MeSH terms
- Blood Glucose, Brain, Cardiovascular System, Cognition, Diabetes Mellitus, Type 1, Electrocardiography, Electroencephalography, Female, Humans, Hypoglycemia, Male, Middle Aged, Receptors, Angiotensin, Glucose Clamp Technique, Angiotensin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.